SCI & TECH● LOWJul 17 · Jul 17, 2026, 6:45 AM
Telix Completes Patient Enrollment in TLX591 - Px ( Illuccix ) Japan Phase 3 Study
malaysiasun.com · Malaysia
Telix has completed patient enrollment for a Phase 3 study of its product TLX591-Px (Illuccix) in Japan. This marks a significant milestone in the product's clinical development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from Malaysia
POLITICS19h agoDo tough laws deter drug crimes? Lessons from Singapore and MalaysiaAl Jazeera [en]POLITICS1d agoMalaysia’s Melaka poll begins as 79 cleared in test for Anwar’s coalitionSouth China Morning PostMILITARY1d agoSaviour or stop gap? Malaysia’s South Korean jets arrive to relieve ageing fightersSouth China Morning PostHEALTH2d agoWhat Women in Indonesia and Malaysia Want From Research on Climate and HealthThe Diplomat
More in Sci & Tech
SCI & TECH1h agoSingapore turns up heat on power-hungry air conditioning with cool revolutionSouth China Morning PostSCI & TECH2h agoHate paper straws? Asia’s new alternatives are another eco trapSouth China Morning PostSCI & TECH5h agoSouth Korea’s latest chart sensation has a secret: the singer isn’t humanSouth China Morning PostSCI & TECH6h agoZohran Mamdani invested 29.2 million dollars in New York University's quantum laboratoryClarín